481
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of a novel series of benzylether-containing cinnamoyl derivatives as histone deacetylase inhibitors

, , , , &
Pages 132-138 | Received 12 Jan 2009, Accepted 28 Apr 2009, Published online: 23 Dec 2009

References

  • Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic(and more) treatments for cancer. Nat Rev Cancer 2006;6:38–51.
  • de Ruijter AJM, an Gennip AH, Caron HN, Kemp S, van Kuilenburg ABP. Histone deacetylases(HDACs): characterization of the classical HDAC family. Biochem J 2003;370:737–49.
  • Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000;92:1210–16.
  • Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 2008;269:7–17.
  • Kim DH, Kim M, Kwon HJ. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol 2003;36:110–19.
  • Pan L, Lu J, Huang B. HDAC inhibitors: a potential new category of anti-tumor agents. Cell Mol Immunol 2007;4:337–43.
  • Acharya MR, Sparreboom A, Venitz J, Figg WD. Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 2005;68(4):917–32.
  • Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 2007;12:1247–52.
  • Patent application US 2000/6541661.
  • Paris M, Porcelloni M, Binaschi M, Fattori D. Histone deacetylase inhibitors: from bench to clinic. J Med Chem 2008;5:1505–29.
  • Wen-Fang X, Jie J. Preparation of cinnamamide derivatives as histone deacetylase inhibitors for treatment of cancer. In: Faming Zhuanli Shenqing Gongkai Shuomingshu 2008:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.